QOL assessment, Neuropsychological

OTHER3 trials

Sponsors

National Cancer Institute (NCI), Hospital Universitari Vall d'Hebron Research Institute, University of Erlangen-Nürnberg Medical School

Conditions

ACTA1Acute Lymphatic LeukemiaCFL2Cohort StudiesKBTBD13KLHL40KLHL41LMOD3

Phase 1

Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

CompletedNCT00727233

National Cancer Institute (NCI)Neurofibromatosis Type I, Plexiform Neurofibroma

Start: 2008-07-08End: 2011-06-16Updated: 2019-12-12

Unknown Phase

Natural History Study for Patients With Nemaline Myopathy in Spain

RecruitingNCT07488806

Hospital Universitari Vall d'Hebron Research InstituteACTA1, CFL2, Cohort Studies +13

Start: 2026-06-01End: 2032-06-01Target: 100Updated: 2026-03-23

More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL)

RecruitingNCT07705178

University of Erlangen-Nürnberg Medical SchoolAcute Lymphatic Leukemia, Lymphoma

Start: 2026-07-14End: 2028-10-31Target: 180Updated: 2026-07-15